Cytochalasin D for Actin-Dependent Uptake Assays
2026-09-07
Cytochalasin D is an actin polymerization inhibitor for testing whether cytoskeletal remodeling drives nanoparticle internalization in corneal epithelial models. This workflow pairs controlled cytoskeletal perturbation with particle-size, surface-chemistry, viability, and localization readouts to distinguish true uptake effects from nonspecific cellular injury.
AG-490 Workflow for JAK2/STAT6 Research
2026-09-05
AG-490, also called Tyrphostin B42, offers a practical pharmacological probe for testing JAK2/STAT6 signaling in exosome-driven macrophage polarization. This workflow combines pathway-focused dosing, EGFR-aware controls, and orthogonal readouts for reproducible cancer research.
DOT1L–Lenalidomide Synergy in Myeloma
2026-09-05
A 2025 Cancer Letters study identifies DOT1L as a preferential epigenetic dependency in multiple myeloma and links its inhibition to DNA-sensing, type I interferon, and HLA class II responses. The work further shows that DOT1L inhibition can potentiate lenalidomide activity by strengthening innate immune gene expression and suppressing IRF4–MYC signaling.
Neurotensin for GPCR Trafficking Studies
2026-09-04
Neurotensin provides a practical way to connect NTR1 activation with receptor recycling and miR-133α responses in gastrointestinal models. This workflow combines time-resolved cell assays, disciplined peptide handling, and fluorescence-data quality control for more reproducible mechanism studies.
Affinity-Purified Goat Anti-Rabbit IgG (H+L) Guide
2026-09-04
Build sensitive Western blot, ELISA, IHC, and immunocytochemistry workflows with an HRP-labeled reagent designed for rabbit primary antibodies. This practical guide connects assay optimization to recent hepatic fibrosis research while separating evidence-based findings from recommended starting conditions.
Cy3 NHS ester (non-sulfonated): Practical Guide
2026-09-03
Cy3 NHS ester (non-sulfonated), SKU A8100, provides an orange-emitting NHS ester for labeling primary amino groups in proteins, peptides, and nucleic acids. It is appropriate when DMSO or DMF can be tolerated, but it is not suitable for water-only labeling workflows or targets that are destabilized by organic co-solvents.
Citron OGD2 and Iron-ROS Defense Against Citrus Canker
2026-09-03
The reference study identifies CmOGD2 as a central regulator of citron resistance to Xanthomonas citri by connecting iron uptake, reactive oxygen species accumulation, and ferroptosis-like cell death. It also reveals a regulatory circuit involving CmENO2, CmZAT10.1, and the pathogen effector pthA4, providing a mechanistic framework for studying nutrient-dependent plant immunity.
Cell Integrity Limits Ploidy in Budding Yeast
2026-09-02
Barker, Murray, and Bell define a physiological ceiling for genome amplification in budding yeast, showing that endoreplicating cells reach approximately 32–64C and that cell-surface stress determines this limit. Their results connect genome copy number, cell growth, membrane-associated integrity, and ergosterol-biosynthesis gene expression, providing a framework for interpreting ploidy stress in fungal biology.
Polybrene Workflows for Mutant p53Y220C Studies
2026-09-02
Polybrene supports reproducible lentiviral and retroviral delivery when building mutant p53Y220C cell models, while careful exposure control helps protect cell health. This guide connects transduction optimization with TRAP-1 response assays and separates delivery effects from genuine p53 reactivation.
Polygodial for TRPA1 Assay Workflows
2026-09-01
Polygodial provides a practical chemical entry point for acute TRPA1 activation, calcium imaging, and downstream epithelial inflammatory assays. This workflow connects channel-level measurements with Ca2+/NFAT-dependent readouts while emphasizing DMSO control, dose optimization, and orthogonal validation.
Patient-Derived Gastric Cancer Assembloids
2026-08-31
A 2025 Cancers study developed patient-derived gastric cancer assembloids by combining matched tumor organoids with separately expanded stromal cell subpopulations. The model reproduced important tumor–stroma effects on gene expression and drug sensitivity, supporting more physiologically relevant studies of resistance and personalized treatment.
β-Pseudouridine: An Assay-First RNA Guide
2026-08-31
β-Pseudouridine is a powerful probe for connecting RNA modification chemistry with structure and translational fidelity. This assay-first guide interprets recent self-amplifying RNA vaccine findings while clarifying what the free nucleoside can—and cannot—demonstrate experimentally.
Honokiol Workflows for NF-κB and Cancer Assays
2026-08-30
Honokiol supports mechanism-focused studies of NF-κB signaling, oxidative stress, viability, and tumor angiogenesis. This workflow shows how to separate growth arrest from cell killing while controlling solvent, timing, and assay-specific artifacts.
Ionomycin free acid: Calcium Signaling Workflows
2026-08-29
Ionomycin free acid provides a direct, controllable way to raise intracellular calcium for live-cell signaling, FAK proteolysis studies, and oocyte activation workflows. This guide translates the FAISL–FAK findings into practical assay designs while separating established evidence from testable calcium-perturbation hypotheses.
Oridonin, MAPK/NF-κB, and Bone Protection
2026-08-29
The 2023 reference study shows that oridonin can counter thioacetamide-associated bone injury through a dual mechanism: suppressing osteoclast differentiation through MAPK/NF-κB and supporting osteoblast differentiation through BMP-2/RUNX2. Its paired cell and animal-model design provides a useful framework for studying bone loss driven by oxidative, inflammatory, and toxicant-related stress.
460 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page